Prevention and treatment studies for CMV open.
D000284:Administration, Oral; D000740:Anemia / Q000139:chemically induced / Q000628:therapy; D003092:Colitis / Q000188:drug therapy / Q000821:virology; D003586:Cytomegalovirus Infections / Q000188:drug therapy / Q000517:prevention & control*; D004921:Erythropoietin / Q000627:therapeutic use; D017245:Foscarnet / Q000627:therapeutic use*; D015774:Ganciclovir / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D007262:Infusions, Intravenous; D009503:Neutropenia / Q000139:chemically induced / Q000628:therapy
D004921:Erythropoietin; D016179:Granulocyte Colony-Stimulating Factor; D017245:Foscarnet; D015774:Ganciclovir